OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW

The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions. We performed a systematic review to describe and provide insight in...

Full description

Bibliographic Details
Main Authors: Dewi Latifatul Ilma, Nialiana Endah Endriastuti
Format: Article
Language:Indonesian
Published: Universitas Muhammadiyah Magelang 2020-04-01
Series:Jurnal Farmasi Sains dan Praktis
Subjects:
Online Access:http://journal.ummgl.ac.id/index.php/pharmacy/article/view/3407
id doaj-f2a6312f37dc49e4a87b39325828f3ea
record_format Article
spelling doaj-f2a6312f37dc49e4a87b39325828f3ea2020-11-25T02:14:45ZindUniversitas Muhammadiyah MagelangJurnal Farmasi Sains dan Praktis2549-90682579-45582020-04-016110.31603/pharmacy.v6i1.3407OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEWDewi Latifatul Ilma0Nialiana Endah EndriastutiUniversitas Jenderal Soedirman The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions. We performed a systematic review to describe and provide insight into off-label pediatric drug use in Indonesia. The articles published using English and Bahasa Indonesia were systematically searched in five electronic databases including Pubmed, Scopus, Google Scholar, Garuda, and Neliti. Key terms used for the search were as follows: “off-label use”, “off-label, “child", "pediatrics", "infant", "adolescent", ”newborn”, “Indonesia”. A total of 116 studies were initially obtained from electronic databases. Further, after the references were reviewed, 10 articles met all the eligibility criterias were finally selected. The percentage of off-label pediatric drug use was 32.6-89.9%. The off-label categories in the selected studies were age, dosage, contraindication, route of administration, and indication. Among these off-label categories, age was the highest off-label with percentages ranged from 19.8 to 92.9%. Pseudoephedrine hydrochloride and triamcinolone acetonide became the most frequently used drug in that category. Thus we conclude that off-label pediatric drug use is common in Indonesia. Future research should consider the safety of off-label drugs in pediatric, primarily in Indonesia. Clinicians should aware of off-label drugs in pediatric and consider the risk-benefit of the drugs when prescribing to children. The authorities need to regulate the off-label drug prescribing in pediatric, therefore could improve medication safety and quality.   http://journal.ummgl.ac.id/index.php/pharmacy/article/view/3407Off-Label DrugPediatricIndonesiaSystematic Review
collection DOAJ
language Indonesian
format Article
sources DOAJ
author Dewi Latifatul Ilma
Nialiana Endah Endriastuti
spellingShingle Dewi Latifatul Ilma
Nialiana Endah Endriastuti
OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
Jurnal Farmasi Sains dan Praktis
Off-Label Drug
Pediatric
Indonesia
Systematic Review
author_facet Dewi Latifatul Ilma
Nialiana Endah Endriastuti
author_sort Dewi Latifatul Ilma
title OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
title_short OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
title_full OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
title_fullStr OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
title_full_unstemmed OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
title_sort off-label pediatric drug use in indonesia : a systematic review
publisher Universitas Muhammadiyah Magelang
series Jurnal Farmasi Sains dan Praktis
issn 2549-9068
2579-4558
publishDate 2020-04-01
description The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions. We performed a systematic review to describe and provide insight into off-label pediatric drug use in Indonesia. The articles published using English and Bahasa Indonesia were systematically searched in five electronic databases including Pubmed, Scopus, Google Scholar, Garuda, and Neliti. Key terms used for the search were as follows: “off-label use”, “off-label, “child", "pediatrics", "infant", "adolescent", ”newborn”, “Indonesia”. A total of 116 studies were initially obtained from electronic databases. Further, after the references were reviewed, 10 articles met all the eligibility criterias were finally selected. The percentage of off-label pediatric drug use was 32.6-89.9%. The off-label categories in the selected studies were age, dosage, contraindication, route of administration, and indication. Among these off-label categories, age was the highest off-label with percentages ranged from 19.8 to 92.9%. Pseudoephedrine hydrochloride and triamcinolone acetonide became the most frequently used drug in that category. Thus we conclude that off-label pediatric drug use is common in Indonesia. Future research should consider the safety of off-label drugs in pediatric, primarily in Indonesia. Clinicians should aware of off-label drugs in pediatric and consider the risk-benefit of the drugs when prescribing to children. The authorities need to regulate the off-label drug prescribing in pediatric, therefore could improve medication safety and quality.  
topic Off-Label Drug
Pediatric
Indonesia
Systematic Review
url http://journal.ummgl.ac.id/index.php/pharmacy/article/view/3407
work_keys_str_mv AT dewilatifatulilma offlabelpediatricdruguseinindonesiaasystematicreview
AT nialianaendahendriastuti offlabelpediatricdruguseinindonesiaasystematicreview
_version_ 1724899924410105856